Endometriosis Clinical Trial
Official title:
Using a Herbal Remedy Extract for the Treatment of Endometriosis Symptoms
A prospective, double-blind, placebo-controlled trial examining the effect of Chinese herbal
medicine combined with curcumin defined as a dietary supplement on a study group of women
with endometriosis, compared to control group.
research product:Chinese herbal extract and curcumin extract, which appear as nutritional
supplements in the Ministry of Health database, the research product is packed in 800mg
capsules.
Intended use: Composition of 14 different nutritional supplements, in Chinese herbal formula,
for the treatment of endometriosis and its symptoms. The formula is formulated according to
Chinese medicine principles and aims to reduce inflammation of the pelvic organs and reduce
the levels of pain caused by endometriosis disease.
Objectives:Examine the Effect of Using Nutritional Supplements on Symptoms in Patients with
Targeted Endometriosis Symptoms.
Primary Endpoints:
Benefit of pain in women suffering from symptoms of endometriosis patients taking herbal
extract for 4 months of treatment.
Structure of the study:A prospective, double-blind, double-blind, placebo-controlled
(randomized) placebo-controlled trial involving women suffering from endometriosis symptoms
and meeting the inclusion and exclusion criteria and who agreed to participate in the study.
The women will be randomly divided into the following two arms:
1. Study Group - Taking a daily dose of dietary supplement extract capsules
2. Control group - take a daily dose of Invo capsules Treatment efficacy will be measured
according to a dedicated patient questionnaire with endometriosis symptoms that assess
quality of life measures.
The study population will include 60 symptomatic women treated at the Multidisciplinary
Center for Endometriosis Therapy at Lynn Medical Center.
Endometriosis is a chronic and progressive gynecological disease, with an estimated invention
of between 8-10% of women of childbearing age in the Western world . The disease is
characterized by the presence of tissue resembling endometrial tissue . The tissue cells that
are in the uterine space can settle on different organs in the pelvis. The cells continue to
respond to the hormonal cycle as if they were inside the uterus and in each menstrual can
grow and bleed. At the same time, an inflammatory process can be associated with various
symptoms of pain. Symptoms are not specific but usually cyclical according to menstrual
timing and include: severe menstrual cramps, heavy bleeding, diarrhea and constipation,
infertility, urinary pain, recurrent infections, fainting, intercourse pain, leg pain and
more.
The current practice is based on the removal of endometriosis lesions in surgery and / or
drug therapy designed to suppress existing lesion activity and prevent lesion recurrence
after surgery. To diagnose endometriosis in a definite way it is necessary to visually
identify the lesions and by biopsy in surgery. In many patients, the symptoms of
endometriosis can be treated pharmacologically and without surgery . Therefore, it is now
widely accepted in many cases to treat pharmacologic anatomy empirically based on an
estimated endometriosis-based diagnosis of appropriate anemia, gynecological examination, and
vaginal ultrasound.
Very little has been investigated regarding the integration of endometriosis phenomena
through complementary medicine that includes herbs and acupuncture, despite the vast clinical
knowledge and experience gained. In the present study, we would like to examine the effect of
complementary medicine that would include a combination of herbal remedies for pain symptoms
in women with endometriosis.
In recent years, the Western world has begun to integrate complementary medicine in various
treatments for chronic diseases and in particular endometriosis . The Chinese language review
included 13 Chinese randomized clinical trials from 1994 to 2000. The studies included 1076
women who received Chinese herbs alone or in combination with recognized drugs . The proposed
mechanism is that the herbs are involved in regulation of the endocrine and immune system and
which improve blood flow and anti-inflammatory activity .
The ability of Chinese herbs to affect physiological changes indicates a mechanism of
biological action of the herbs. However, the medicinal plants appear to have lower potency
activity than synthetic drugs. They can contain an anti-inflammatory but less active
ingredient than synthetic steroids.
Research Rationale Endometriosis is a chronic disease of infertile women. The main treatment
is based on hormone drug therapy and surgical treatment. There are patients who, despite
these treatments, still suffer from symptoms of endometriosis. There are also patients who
are medically balanced but have to stop treatment for various reasons and need another
non-hormonal response. Herbs have been found effective in treating gynecological problems and
especially in chronic pelvic pain. They may relieve the symptoms in those women who wish to
avoid hormone or surgical treatment or who are not symptomatically balanced despite the usual
treatments.
The purpose of the study Investigate the effectiveness of treatment of symptoms and quality
of life measures by the use of medicinal plants in women with symptoms of endometriosis.
Preliminary Results Primary Endpoints Benefit of pain indices in women suffering from
symptoms of endometriosis between patients taking herbal extract and patients taking Invo for
4 months of treatment. Benefit is defined as a statistically significant improvement in VAS
dimensions that will be examined by a daily journal and medical questionnaire.
Secondary Results Secondary Endpoints Quality-Of-Life Benefit Defined as a statistically
significant improvement in questionnaire indices.
Also, a reduction in the use of painkillers and a lack of working days each month between the
two groups.
The research product:Chinese herbal extract and curcumin extract, which appear as nutritional
supplements in the Ministry of Health database, the research product is packed in 800mg
capsules.
Intended use: Composition of 14 different nutritional supplements, in Chinese herbal formula,
for the treatment of endometriosis and its symptoms. The formula is formulated according to
Chinese medicine principles and aims to reduce inflammation of the pelvic organs and reduce
the levels of pain caused by endometriosis disease.
Objectives:Examine the Effect of Using Nutritional Supplements on Symptoms in Patients with
Targeted Endometriosis Symptoms.
Primary Endpoints:
Benefit of pain indices in women suffering from symptoms of endometriosis between patients
taking herbal extract and patients taking Invo for 4 months of treatment.
Structure of the study:A prospective, double-blind, double-blind, placebo-controlled
(randomized) placebo-controlled trial involving women suffering from endometriosis symptoms
and meeting the inclusion and exclusion criteria and who agreed to participate in the study.
The women will be randomly divided into the following two arms:
1. Study Group - Taking a daily dose of dietary supplement extract capsules
2. Control group - take a daily dose of Invo capsules Treatment efficacy will be measured
according to a dedicated patient questionnaire with endometriosis symptoms that assess
quality of life measures.
The study population will include 60 symptomatic women treated at the Multidisciplinary
Center for Endometriosis Therapy at Lynn Medical Center.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01931670 -
A Global Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
|
Phase 3 | |
Recruiting |
NCT05648669 -
A Study to Evaluate Safety and Efficacy of Elagolix in Patients With Moderate to Severe Endometriosis-Associated Pain
|
Phase 3 | |
Completed |
NCT04081532 -
The Effectiveness of Laparoscopic Treatment of Superficial Endometriosis for Managing Chronic Pelvic Pain
|
N/A | |
Recruiting |
NCT06101303 -
Endometriosis Pain
|
||
Completed |
NCT04665414 -
Diagnosis of Adenomyosis Using Ultrasound, Elastography and MRI
|
||
Completed |
NCT03690765 -
Study of Real Clinical Practice to Evaluate the Effects of Oral Dydrogesterone for Treatment of Confirmed Endometriosis
|
||
Recruiting |
NCT05153512 -
ADOlescent DysmenoRrhea Endometriosis Assessment Magnetic Resonance Imaging (Adodream)
|
||
Active, not recruiting |
NCT04171297 -
Ultrasound Evaluation of the Pelvis in Women With Suspected Endometriosis Scheduled for Laparoscopic Surgery
|
||
Recruiting |
NCT04172272 -
The Influence of TAP Block in the Control of Postoperative Pain After Laparotomy for Gynecological Procedures
|
N/A | |
Completed |
NCT04565470 -
Strategies of Self-management of Endometriosis Symptoms
|
||
Completed |
NCT03613298 -
Treatment by HIFU With Focal One® of Posterior Deep Infiltrating Endometriosis Lesions With Intestinal Involvement.
|
N/A | |
Withdrawn |
NCT05568940 -
Evaluating Tibolone Add-back in Patients With Endometriosis and Fibroids
|
||
Not yet recruiting |
NCT03464799 -
Does Immunotherapy Have a Role in the Management of Endometriosis?
|
||
Active, not recruiting |
NCT03002870 -
Characteristics of Patient Population With Endometriosis
|
N/A | |
Withdrawn |
NCT03272360 -
Endometriosis Biomarker Discovery Study
|
N/A | |
Completed |
NCT02973854 -
Activation of the Sphingosine-1-phosphate (S1P) to S1P1 Receptor Subtype (S1PR1) Axis in Patients With Endometriosis: Identification of Potential Relevant Biomarkers to Diagnose and Treat
|
||
Recruiting |
NCT02481739 -
Laparoscopic Surgical Management of Endometriosis on Fertility
|
N/A | |
Active, not recruiting |
NCT02754648 -
Three Different Laparoscopic Approaches for Ovarian Endometrioma and the Effect on Ovarian Reserve
|
N/A | |
Completed |
NCT06106932 -
GnRH-a on Angiogenesis of Endometriosis
|
N/A | |
Completed |
NCT02387931 -
Supplementation in Adolescent Girls With Endometriosis
|
Phase 4 |